Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Dna X (SONM) Receivables - Other (2020 - 2025)

Dna X filings provide 6 years of Receivables - Other readings, the most recent being $9.8 million for Q3 2025.

  • On a quarterly basis, Receivables - Other rose 1428.11% to $9.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $9.8 million, a 1428.11% increase, with the full-year FY2024 number at $181000.0, down 81.17% from a year prior.
  • Receivables - Other hit $9.8 million in Q3 2025 for Dna X, up from $7.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $9.8 million in Q3 2025 to a low of $181000.0 in Q4 2024.
  • Median Receivables - Other over the past 5 years was $1.9 million (2021), compared with a mean of $2.7 million.
  • The widest YoY moves for Receivables - Other: up 1428.11% in 2025, down 96.89% in 2025.
  • Dna X's Receivables - Other stood at $2.3 million in 2021, then grew by 0.62% to $2.3 million in 2022, then crashed by 57.65% to $961000.0 in 2023, then crashed by 81.17% to $181000.0 in 2024, then soared by 5337.02% to $9.8 million in 2025.
  • The last three reported values for Receivables - Other were $9.8 million (Q3 2025), $7.0 million (Q2 2025), and $181000.0 (Q1 2025) per Business Quant data.